Myomo (MYO) Non-Current Deferred Tax Liability (2024)

Myomo (MYO) posted Non-Current Deferred Tax Liability of $1.9 million for Q4 2024.

Myomo (MYO) Non-Current Deferred Tax Liability (2024) Analysis & Trends

Myomo's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $1.9 million for Q4 2024.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $1.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.9 million (changed N/A YoY) and the FY2024 annual result came in at $1.9 million, changed N/A from the prior year.
Non-Current Deferred Tax Liability was $1.9 million for Q4 2024 at Myomo.
Across five years, Non-Current Deferred Tax Liability topped out at $1.9 million in Q4 2024 and bottomed at $1.9 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	180.89 Bn	173.59 Bn	6.27 Bn
2	Stryker	127.82 Bn	124.94 Bn	3.81 Bn
3	Medtronic	107.49 Bn	98.27 Bn	6.41 Bn
4	Boston Scientific	67.24 Bn	65.78 Bn	3.61 Bn
5	Edwards Lifesciences	48.02 Bn	44.34 Bn	1.29 Bn
6	Dexcom	28.25 Bn	27.14 Bn	750.30 Mn
7	GE HealthCare Technologies	28.17 Bn	25.89 Bn	1.98 Bn
8	Smith & Nephew	26.72 Bn	26.14 Bn	-
9	Koninklijke Philips	25.31 Bn	22.19 Bn	2.07 Bn
10	Myomo	43.43 Mn	24.46 Mn	-

Download Data

Date	Value
Dec 31, 2024	1.87 Mn
Dec 31, 2024	1.87 Mn